Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex

European Neuropsychopharmacology

Volumn 21, Issue 1, 2011, Pages 23-32

  Tordera, R M ^a   Garcia Garcia A L ^a   Elizalde, N ^a   Segura, V ^b   Aso, E ^c   Venzala, E ^a   Ramirez M J ^a   Del Rio, J ^d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Animal models; Chronic mild stress; Gene expression.; Major depression; VGLUT1

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOREDUCTASE; SEROTONIN RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 1;

AEROBIC METABOLISM; ANAPC7 GENE; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC STRESS; CONTROLLED STUDY; CSNK1G1 GENE; CYTOSKELETON; DEPRESSION; DIDO1 GENE; DOWN REGULATION; DUSP14 GENE; EIF4A2 GENE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; FRONTAL CORTEX; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC RISK; GPX2 GENE; GRIN1 GENE; HDAC3 GENE; HELPLESSNESS; HSPG2 GENE; INVS GENE; LEARNING; MAJOR DEPRESSION; MAPK12 GENE; MEMORY; MICROARRAY ANALYSIS; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METABOLISM; RAB8B GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MOOD DISORDERS; NEUROTRANSMITTER AGENTS; PHENOTYPE; PLEASURE; RNA; STRESS, PSYCHOLOGICAL; SUCROSE; TIME FACTORS; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 78650678943     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.06.016     Document Type: Article

References (57)

1. Airan R.D., Meltzer L.A., Roy M., Gong Y., Chen H., Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007, 317:819-823.
2. Aso E., Ozaita A., Valdizán E.M., Ledent C., Pazos A., Maldonado R., Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem 2008, 105:565-572.
3. Aso E., Ozaita A., Serra M.A., Maldonado R. Genes differentially expressed in CB1 knockout mice:involvement in the depressive-like phenotype. Eur Neuropsychopharmacol 2011, 21:11-22. (this issue).
4. Balschun D., Moechars D., Callaerts-Vegh Z., Vermaercke B., Van Acker N., Andries L., D'Hooge R. Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex 2009, 20:684-693.
5. Banasr M., Chowdhury G.M., Terwilliger R., Newton S.S., Duman R.S., Behar K.L., Sanacora G. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 2009, 15:501-511.
6. Bassi C., Mello S.S., Cardoso R.S., Godoy P.D., Fachin A.L., Junta C.M., Sandrin-Garcia P., Carlotti C.G., Falcao R.P., Donadi E.A., et al. Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation. Hum Exp Toxicol 2008, 27:919-929.
7. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., Matthews P.M., Cowen P.J. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry 2007, 61:806-812.
8. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
9. Brambilla P., Perez J., Barale F., Schettini G., Soares J.C. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003, 8(721-737):715.
10. Cheyssac C., Dina C., Lepretre F., Vasseur-Delannoy V., Dechaume A., Lobbens S., Balkau B., Ruiz J., Charpentier G., Pattou F., et al. EIF4A2 is a positional candidate gene at the 3q27 locus linked to type 2 diabetes in French families. Diabetes 2006, 55:1171-1176.
11. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
12. Dunning M.J., Smith M.L., Ritchie M.E., Tavare S. Beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 2007, 23:2183-2184.
13. Elizalde N., Gil-Bea F.J., Ramirez M.J., Aisa B., Lasheras B., Del Rio J., Tordera R.M. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology (Berl) 2008, 199:1-14.
14. Farach-Carson M.C., Brown A.J., Lynam M., Safran J.B., Carson D.D. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biol 2008, 27:150-160.
15. Fremeau R.T., Troyer M.D., Pahner I., Nygaard G.O., Tran C.H., Reimer R.J., Bellocchio E.E., Fortin D., Storm-Mathisen J., Edwards R.H. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 2001, 31:247-260.
16. Fremeau R.T., Kam K., Qureshi T., Johnson J., Copenhagen D.R., Storm-Mathisen J., Chaudhry F.A., Nicoll R.A., Edwards R.H. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 2004, 304:1815-1819.
17. Frodl T.S., Koutsouleris N., Bottlender R., Born C., Jager M., Scupin I., Reiser M., Moller H.J., Meisenzahl E.M. Depression-related variation in brain morphology over 3years: effects of stress?. Arch Gen Psychiatry 2008, 65:1156-1165.
18. Futterer A., Campanero M.R., Leonardo E., Criado L.M., Flores J.M., Hernandez J.M., San Miguel J.F., Martinez A.C. Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms. J Clin Invest 2005, 115:2351-2362.
19. Garcia-Garcia A.L., Elizalde N., Matrov D., Harro J., Wojcik S.M., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 2009, 66:275-282.
20. Georgi A., Jamra R.A., Klein K., Villela A.W., Schumacher J., Becker T., Paul T., Schmael C., Hofels S., Klopp N., et al. Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr Genet 2007, 17:308-310.
21. Gerges N.Z., Backos D.S., Esteban J.A. Local control of AMPA receptor trafficking at the postsynaptic terminal by a small GTPase of the Rab family. J Biol Chem 2004, 279:43870-43878.
22. Gieffers C., Dube P., Harris J.R., Stark H., Peters J.M. Three-dimensional structure of the anaphase-promoting complex. Mol Cell 2001, 7:907-913.
23. Gould N.F., Holmes M.K., Fantie B.D., Luckenbaugh D.A., Pine D.S., Gould T.D., Burgess N., Manji H.K., Zarate C.A. Performance on a virtual reality spatial memory navigation task in depressed patients. Am J Psychiatry 2007, 164:516-519.
24. Gratacos M., Costas J., de Cid R., Bayes M., Gonzalez J.R., Baca-Garcia E., de Diego Y., Fernandez-Aranda F., Fernandez-Piqueras J., Guitart M., et al. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:808-816.
25. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res 2007, 181:42-51.
26. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc. 2009, 4:44-57.
27. Jayatissa M.N., Bisgaard C.F., West M.J., Wiborg O. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 2008, 54:530-541.
28. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999, 156:837-841.
29. Kendler K.S., Thornton L.M., Gardner C.O. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001, 158:582-586.
30. Kessler R.C. The effects of stressful life events on depression. Annu Rev Psychol 1997, 48:191-214.
31. Klinger S., Poussin C., Debril M.B., Dolci W., Halban P.A., Thorens B. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes 2008, 57:584-593.
32. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., Epperson C.N., Goddard A., Mason G.F. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002, 7(Suppl 1):S71-S80.
33. Kusuda J., Hirai M., Tanuma R., Hashimoto K. Cloning, expression analysis and chromosome mapping of human casein kinase 1 gamma1 (CSNK1G1): identification of two types of cDNA encoding the kinase protein associated with heterologous carboxy-terminal sequences. Cytogenet Cell Genet 2000, 90:298-302.
34. Lucassen P.J., Heine V.M., Muller M.B., van der Beek E.M., Wiegant V.M., De Kloet E.R., Joels M., Fuchs E., Swaab D.F., Czeh B. Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 2006, 5:531-546.
35. Massat I., Souery D., Del-Favero J., Oruc L., Noethen M.M., Blackwood D., Thomson M., Muir W., Papadimitriou G.N., Dikeos D.G., et al. Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study. Mol Psychiatry 2002, 7:201-207.
36. Mathews G.C., Diamond J.S. Neuronal glutamate uptake contributes to GABA synthesis and inhibitory synaptic strength. J Neurosci 2003, 23:2040-2048.
37. Moechars D., Weston M.C., Leom S., Callaerts-Vegh Z., Goris I., Daneels G., Buist A., Cik M., van der Spek P., Kass S. Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 2006, 26:12055-12066.
38. Monroe S.M., Simons A.D., Thase M.E. Onset of depression and time to treatment entry: roles of life stress. J Consult Clin Psychol 1991, 59:566-573.
39. Monroe S.M., Torres L.D., Guillaumot J., Harkness K.L., Roberts J.E., Frank E., Kupfer D. Life stress and the long-term treatment course of recurrent depression: Nonsevere life events predict recurrence for medicated patients over 3 years. J Consult Clin Psychol 2006, 74:112-120.
40. Nurnberger J., Kribben A., Opazo Saez A., Heusch G., Philipp T., Phillips C.L. The Invs gene encodes a microtubule-associated protein. J Am Soc Nephrol 2004, 15:1700-1710.
41. Park C., Falls W., Finger J.H., Longo-Guess C.M., Ackerman S.L. Deletion in Catna2, encoding alpha N-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation. Nat Genet 2002, 31:279-284.
42. Qi X., Lin W., Li J., Pan Y., Wang W. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav Brain Res 2006, 175:233-240.
43. Rachidi W., Mange A., Senator A., Guiraud P., Riondel J., Benboubetra M., Favier A., Lehmann S. Prion infection impairs copper binding of cultured cells. J Biol Chem 2003, 278:14595-14598.
44. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000, 48:766-777.
45. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003, 121:109-122.
46. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004, 61:705-713.
47. Sasaki T., Iwata S., Okano H.J., Urasaki Y., Hamada J., Tanaka H., Dang N.H., Okano H., Morimoto C. Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia. Stroke 2005, 36:2457-2462.
48. Strekalova T., Spanagel R., Bartsch D., Henn F.A., Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29:2007-2017.
49. Strekalova T., Gorenkova N., Schunk E., Dolgov O., Bartsch D. Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol 2006, 17:271-287.
50. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci 2001, 21:RC182.
51. Tordera R.M., Totterdell S., Wojcik S.M., Brose N., Elizalde N., Lasheras B., Del Rio J. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci 2007, 25:281-290.
52. Tunnicliff G., Malatynska E. Central GABAergic systems and depressive illness. Neurochem Res 2003, 28:965-976.
53. Uezato A., Meador-Woodruff J.H., McCullumsmith R.E. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar Disord 2009, 11:711-725.
54. Warner-Schmidt J.L., Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006, 16:239-249.
55. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
56. Wojcik S.M., Rhee J.S., Herzog E., Sigler A., Jahn R., Takamori S., Brose N., Rosenmund C. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci U S A 2004, 101:7158-7163.
57. Xia Y., Wang J., Liu T., Yung W., Hunter T., Lu Z. c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis. Molecular Cell. 2002, 25:219-232.